Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
IPO Year: 2022
Exchange: NYSE
Website: https://www.ehab.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/14/2024 | $8.50 | Underperform → Market Perform | Leerink Partners |
5/9/2024 | $14.00 → $8.75 | Buy → Hold | Jefferies |
3/7/2024 | $9.50 | Sell → Neutral | UBS |
12/12/2023 | $12.00 | Market Perform | TD Cowen |
6/20/2023 | $10.00 | Underperform | SVB Securities |
3/16/2023 | $15.00 | Neutral | Goldman |
12/13/2022 | $18.00 | Market Perform | CJS Securities |
12/8/2022 | $12.00 | Sell | UBS |
12/6/2022 | $17.00 | Buy | Stifel |
10/14/2022 | Perform | Oppenheimer |
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its participation in two upcoming investor conferences. Enhabit's President and Chief Executive Officer Barb Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in the following events: Jefferies Healthcare Services "Back to School" Summit and Bus Tour When: Aug. 28 Venue: 1 Hotel Nashville in Nashville, Tenn. 2024 Wells Fargo Healthcare Conference When: Investor meetings and a fireside chat on Sept. 5 Venue: Encore Boston Harbor in Boston, Mass. The fireside chat will be webcast live at 11 a.m. EDT and available for replay at https://investors.ehab.com under
Enhabit, Inc. (NYSE:EHAB), ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contribu
Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. "The second quarter marked our third sequential quarter demonstrating the success of our strategies," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "In our home health segment, our total admissions growth of 6.4% was driven by our payor innovation strategy and our focus on improved utilization of our clinical resources. In our hospice segment, we continued to make steady progress in growing our census, with average daily census in
Leading Proxy Advisors and Stockholders Supported Mandate for Change AREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), today commented on the outcome of Enhabit's 2024 Annual Meeting of Stockholders (the "Annual Meeting"), in which stockholders elected Mark W. Ohlendorf to the Company's board of directors (the "Board"). AREX Managing Partner, Andrew Rechtschaffen, and Partner, James T. Corcoran, commented: "We are pleased that stockholders have elected Mark W. Ohlendorf to the Board. Mark will add critically needed financial expertise
Enhabit, Inc. (NYSE:EHAB) (the "Company"), a leading home health and hospice provider, today announced that the preliminary vote count of its proxy solicitor indicates that its stockholders have voted to elect eight of Enhabit's director nominees at the 2024 Annual Meeting of Stockholders: Jeffrey W. Bolton Tina L. Brown-Stevenson Charles M. Elson Erin P. Hoeflinger Barbara A. Jacobsmeyer Stuart M. McGuigan Gregory S. Rush Barry P. Schochet Additionally, the preliminary vote count of the Company's proxy solicitor indicates that stockholders voted to elect one nominee proposed by AREX Capital Management, LP: Mark W. Ohlendorf The results announced today are c
Reiterates that Two Leading Proxy Advisory Firms Have Recommended Stockholders Support Meaningful Change to Enhabit's Board Reminds Stockholders that Enhabit Has Historically Made Excuses for Poor Performance and Empty Promises Underscores Opportunity Stockholders Have to Add Industry-Specific Expertise to Enhabit's Board at the Annual Meeting on July 25th AREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), today issued an open letter to its fellow stockholders asking them to address the deficiencies of Enhabit's current board of direct
Enhabit has Achieved Three Consecutive Quarters of Strong Operational Results – Demonstrating the Company is Executing the Right Plan and Strategy with the Right Board to Drive Value Creation Enhabit's Nominees Possess Deep Experience with the Three Key Drivers of Its Business AREX Makes Bold Statements about their Candidates' Histories and Individual Track Records that are Inconsistent with the Actual Roles Held by the Candidates Recommends Stockholders Vote "FOR" ONLY Enhabit's Nine Highly Qualified Director Nominees on the YELLOW Proxy Card Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today reminded stockholders to protect th
Glass Lewis Concludes That Support is Merited for AREX Nominees to Add "Fresh Perspectives and Relevant Expertise" Two Leading Independent Proxy Advisory Firms Recognize That Boardroom Change is Urgently Needed at Enhabit AREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), today announced that Glass, Lewis & Co. ("Glass Lewis"), a leading independent proxy advisory firm, has recommended that Enhabit's stockholders support significant boardroom change by voting for three of its director candidates at the Company's 2024 Annual Meeting of St
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an incr
ISS Concludes Support Is Warranted for AREX Nominees to Add Beneficial Industry-Specific Expertise and "Oversight Over the Company's Financial Reporting and Shareholder Communications" ISS Recognizes "The Most Apparent Needs for the Board Are Additional Expertise Related to Home Health, Hospice, and Public Company Financial Reporting" AREX Urges Stockholders to Elect Its Full Slate to Ensure Enhabit Has a Board with the Necessary Industry-Specific Experience to Oversee and Guide Management AREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Compan
Enhabit, Inc. (NYSE:EHAB), ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contribu
Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. "The second quarter marked our third sequential quarter demonstrating the success of our strategies," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "In our home health segment, our total admissions growth of 6.4% was driven by our payor innovation strategy and our focus on improved utilization of our clinical resources. In our hospice segment, we continued to make steady progress in growing our census, with average daily census in
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an incr
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Aug. 7, 2024 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/154318091 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice
Company to host a conference call tomorrow, May 9, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2024. "Our momentum exiting 2023 and through the first quarter of 2024 instills confidence and excitement in our strategy and team," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "Our strong start to 2024 is a result of our team's continued focus on our operational strategies. Additional frontline clinicians, more and better home health payor contracts and controlling general and administrative expenses were the key drivers of our performa
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2024, on May 8, 2024, and host a webcast and conference call on May 9, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 9, 2024 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/834974223 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enh
Company to host a conference call tomorrow, March 7, 2024, at 10 A.M. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2023. "Persistent focus on our Company's strategies drove our positive fourth quarter results," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "Payor innovation success, including the finalization of another new national contract, continued success with our people strategy and strong performance in our quality outcomes are but a few of our high points for the end of 2023 and our start to 2024. We are excited about our future and our a
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2023, on March 6, 2024, and host a webcast and conference call on March 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 7, 2024 10:00 a.m. Eastern Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/272381846 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health &
Revises Full-Year Guidance Company to host a conference call tomorrow, November 8, 2023 at 10 AM EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2023. "In the midst of industry disruption associated with Medicare reimbursement uncertainty, labor pressures and the shift to Medicare Advantage, we continue to deliver on our mission of providing exceptional care to our patients," said Enhabit's President and Chief Executive Officer, Barb Jacobsmeyer. "We are winning the war for labor as demonstrated by our recruitment of an additional 166 net new nursing hires in the third qu
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today provided updates on the timing for release of its results for the third quarter ended Sept. 30, 2023, and certain other matters. The Company is in the process of closing its books for the third quarter ended Sept. 30, 2023, and will report its results on Nov. 7, 2023, and host a webcast and conference call on Nov. 8, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 8, 2023 10:00 a.m. Eastern Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events
10-Q - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
DEFA14A - Enhabit, Inc. (0001803737) (Filer)
DFAN14A - Enhabit, Inc. (0001803737) (Subject)
DEFA14A - Enhabit, Inc. (0001803737) (Filer)
DFAN14A - Enhabit, Inc. (0001803737) (Subject)
Reiterates that Two Leading Proxy Advisory Firms Have Recommended Stockholders Support Meaningful Change to Enhabit's BoardReminds Stockholders that Enhabit Has Historically Made Excuses for Poor Performance and Empty PromisesUnderscores Opportunity Stockholders Have to Add Industry-Specific Expertise to Enhabit's Board at the Annual Meeting on July 25thAREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), today issued an open letter to its fellow stockholders asking them to address the deficiencies of Enhabit's current board of directors by ele
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an increase f
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2F4b216008-24ac-4184-9324-3ce8da548a35.usrfiles.com%2Fugd%2F4b2160_2a4b9d87603040aca08fa852fe969a2d.pdf&esheet=54090927&newsitemid=20240705086860&lan=en-US&anchor=Enhabit%26%238217%3Bs+Excuses+and+Empty+Promises&index=1&md5=a39bf52df03457cf5c388c4f47b336bb
Recent Results Demonstrate Improving Performance Despite HeadwindsBoard Has Taken Decisive Actions in Light of the Challenges Faced by Enhabit Since the SpinEnhabit's Proposed Board is Specifically Designed to Possess Relevant Industry and Public Company Oversight ExpertiseAREX's Proposal to Take Control of the Board is Not in the Best Interests of StockholdersStockholders Urged to Vote FOR Enhabit's Director Nominees on the YELLOW Proxy CardEnhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced that it has posted an investor presentation today in connection with its Annual Meeting of Stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockh
B of A Securities analyst Joanna Gajuk maintains Enhabit (NYSE:EHAB) with a Underperform and lowers the price target from $9 to $8.
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. In connection with the filing of its definitive proxy statement, Enhabit is mailing a letter to stockholders. Enhabit's definitive proxy materials and other materials regarding the Board of Directors' recommendation for the 2024 Annual Meeting can be f
The Company is filing a preliminary proxy statement because AREX Capital Management, LP has notified the Company that it intends to nominate seven candidates for election to the Company's nine-member board at the 2024 Annual Meeting. On May 8, 2024, having received no formal proposals, the Company announced that the Board had unanimously determined to terminate the strategic review.
Throughout the last three months, 5 analysts have evaluated Enhabit (NYSE:EHAB), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 2 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $10.35, a high estimate of $14.00, and a low estimate of $8.50. This current average represents a 24.29% decrease from the previo
Leerink Partners analyst Whit Mayo upgrades Enhabit (NYSE:EHAB) from Underperform to Market Perform and announces $8.5 price target.
Jefferies analyst Brian Tanquilut downgrades Enhabit (NYSE:EHAB) from Buy to Hold and lowers the price target from $14 to $8.75.
4 - Enhabit, Inc. (0001803737) (Issuer)
3 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
3 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50
Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously
UBS upgraded Enhabit Inc. from Sell to Neutral and set a new price target of $9.50
TD Cowen initiated coverage of Enhabit Inc. with a rating of Market Perform and set a new price target of $12.00
SVB Securities initiated coverage of Enhabit Inc. with a rating of Underperform and set a new price target of $10.00
Goldman initiated coverage of Enhabit Inc. with a rating of Neutral and set a new price target of $15.00
CJS Securities initiated coverage of Enhabit Inc. with a rating of Market Perform and set a new price target of $18.00
UBS initiated coverage of Enhabit Inc. with a rating of Sell and set a new price target of $12.00
Stifel initiated coverage of Enhabit Inc. with a rating of Buy and set a new price target of $17.00
Oppenheimer initiated coverage of Enhabit Inc. with a rating of Perform
Files Definitive Proxy Materials and Mails Letter to Stockholders AREX's Unqualified Slate of Nominees Risks Detracting from the Talent Currently on the Board Urges Stockholders to Vote "FOR" Only Enhabit's Nine Nominees on the YELLOW Proxy Card Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting.
Files Preliminary Proxy Statement; Elaborates on AREX Capital Management's Singular Focus in Demanding a Sale of the Company Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company") today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the "SEC") in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting"). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com. The Company is filing a preliminary proxy statement because AREX Capital Management, LP (together with its affiliates and associates, "AREX") has notified the Company that
Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced the appointment of Dylan Black as general counsel, effective January 2023. "We are excited to welcome Dylan to the Enhabit team," Enhabit President and CEO Barb Jacobsmeyer said. "He has served as a trusted legal advisor to many organizations, and we look forward to the leadership and contributions he will bring to Enhabit." Black brings more than 24 years of legal experience helping publicly traded companies. Most recently, Black served as a partner at Bradley Arant Boult Cummings LLP where he represented companies across various industries including health care, banking and environmental services. In